Navigation Links
Spinach Everyday keeps Skin Cancer At Bay

Recent study confirms that the use of spinach in the diet will enhance the integrity of the skin thereby preventing skin damage.//

People who had earlier developed skin cancer have to exercise caution that they do not develop it again. They have to take care of their skin by using hats and sunscreen. To make the skin further resistant to UV rays, they have to take some nutrients. Spinach is an excellent source of vitamins and minerals and has anti-carcinogenic properties.

The Queensland Institute of Medical Research conducted a 11 year study on 1,000 people at Nambour, on the Sunshine Coast. The rate of developing skin cancer was reduced to 45% among people who consumed about three servings of greens per week.

According to Dr Van der Pols, “Green leafy vegetables are a good source of folic acid, vitamins A, C and E, the carotenoids, lutein and zeaxanthin and other components which may help to boost the skin's natural defense against the damage caused by the UV rays”.

She also stressed the importance of a balanced diet. It is important to understand that diet does play a role in preventing skin cancer but only in addition to the precautionary measures such as using a hat, sunscreen and protective clothing.' Have you had your bowl of spinach today?

KL
'"/>




Page: 1

Related medicine news :

1. Food Safety Extension Specialist Provides Spinach E. coli Advice
2. Spinach Contamination Traced to Wild Boar
3. Salmonella Contamination Suspected In A Brand Of Fresh Spinach
4. At Least 25 Women Die Of Maternity Complications In MP Everyday
5. Tilt the Scales in Your Favor by Simply Weighing Yourself Everyday!
6. 75 Filipinos Afflicted With TB Die Everyday
7. Garlic a day keeps cancer away
8. Caffeine keeps soldiers sharp
9. Gene block keeps mice from increasing weight
10. Flossing everyday keeps tooth decay away
11. Exercise keeps ‘Alzheimer’s Awa’
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Spinach Everyday keeps Skin Cancer Bay

(Date:10/10/2008)... Topics range from bullying to incorporati...ton (Vocus) October 10, 2008 -- Several pediatric ...will be presenting at the 2008 American Academy of...ich runs from October 11 - 14 in Boston. Presenter...Dana Best, MD, MPH, will present "Promoting S...
(Date:10/10/2008)...STRANO, Calif., Oct. 10 /PRNewswire/ -- A senior c... Uinta Mountains in a small,plane. The high-flying...oy,Heden. The thrill came from a last-wish program...erado Senior Living, where Heden was a patient.,Ca...rds and it has helped,many realize a special activ...
(Date:10/10/2008)...or self-care partly to blame , , FRIDAY,...e beneficiaries who have diabetes, being depressed...g to a new study. , Publishing in the October...e , researchers from the University of Washington ... of 75.6 years) who had diabetes and were enrolled...
(Date:10/10/2008)... The Healthcare Technology Evolution: Smar... Exton, PA (PRWEB) September 17, 200...f the national Healthcare Information Management S...ng regional health information technology professi...ntitled The Healthcare Technology Evolution: Smart...
Breaking Medicine News(10 mins):Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference 2Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...st preoccupation driving people to unimaginable le...ng to a new investigation by Forbes magazine. Inst...o pass, the sleepless actually spend waking// hour... winks ! This is boom time for sleep inducing gadg...
...ll scientist has been suspended by the Seoul Natio... other researchers. This measure was taken as the ...search work.// The seven professors are banned wit...y or conducting research. They may face permanent ...
...new reasons and factors responsible for unhealthy ...e from soft drink incentives, and parents who brin...his new information may be useful to school wellne...ping wellness policies as mandated by the Child Nu...
...has revealed that India can easily become a market... for HIV across the world. Several people in the A...ess to HIV drugs.// India is in a position to prov... also contribute the trained health personnel badl...
Other Medicine News:Health News:The trident of unhealthy teen choices is early Lunch, Soft Drink Machine Income and Parents who relent 2
(Date:10/8/2008)...ance, Oct. 8 /- Vical Incorporated (N...al data and new nonclinical data,demonstrating tha...ly,applicable in DNA- and protein-based infectious...s. Alain P. Rolland, Pharm.D., Ph.D., Vical,s,Seni...sent the data today,Wednesday, October 8, at the ...
(Date:10/7/2008)...Texas, Oct. 7 /- The Texas Cardiac Ar...enter has been selected as one of,only a few sites...linical,trial for a new device to treat persistent...ment, training and research center specializing in...St. David,s Medical Center and,Texas Cardiovascula...
(Date:10/7/2008)...nical study of adults, VYVANSE taken once-daily si...ne week, PHILADELPHIA, Oct. 7 /PRNewswire-FirstCa...obal specialty biopharmaceutical company, today,an...sue of the Journal of,Clinical Psychiatry found on...Deficit Hyperactivity Disorder (ADHD) symptoms in ...
(Date:10/7/2008)...abstracts highlighting CIMZIA,s long-term benefits...atients presented at American College,of Gastroent...irstCall/ -- Data from two studies,presented this ...ology,(ACG) Annual Meeting demonstrate that CIMZIA...-TNF alpha (Tumor Necrosis Factor alpha) - provide...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9University of Pennsylvania School of Medicine Study Shows Significant Differences in English and Spanish speakers Use of Oncology Websites 721 1University of Pennsylvania School of Medicine Study Shows Significant Differences in English and Spanish speakers Use of Oncology Websites 721 2University of Pennsylvania School of Medicine Study Shows Significant Differences in English and Spanish speakers Use of Oncology Websites 721 3Substance abuse practitioners ask what is recovery 3F 5226 1Substance abuse practitioners ask what is recovery 3F 5226 2New electronic health records demonstration project encouraging step says ACP 5224 1New electronic health records demonstration project encouraging step says ACP 5224 2Genes identified to protect brassicas from damaging disease 1073 1Genes identified to protect brassicas from damaging disease 1073 2
...Collection Tubes are 100% plastic capillary blood ...applications, the Capillary Collection Tubes are p...nd a micro tube.,The capillary tube uses capi... thereby eliminating the tendency for scooping. Be...
...Collection Tubes are 100% plastic capillary blood ...applications, the Capillary Collection Tubes are p...nd a micro tube.,The capillary tube uses capi... thereby eliminating the tendency for scooping. Be...
...Collection Tubes are 100% plastic capillary blood ...applications, the Capillary Collection Tubes are p...nd a micro tube.,The capillary tube uses capilla...ereby eliminating the tendency for scooping. Becau...
Diagnostic serology for Toxoplasmosis has progressed from the use of a specialized dye test to immunoflourescence, latex and enzyme immunoassay (EIA) techniques. In addition to Toxo IgG indirect EIA
Medicine Products: